Hemila and colleagues reported that various high-dose intravenous VC infusions (e.g., 200 mg/kg body weight/day, divided into 4 doses) shortened the intensive care unit (ICU) stay by 7.8% [11], accompanied by a significant reduction in the mortality rate
Infusion of Vitamin C resulted in COVID-19 patients facing less severity in symptoms, leading to them staying in the ICU for a shorter period of time and also significantly reducing their probability of death. This is really promising proof towards my proposed hypothesis.